US 6,932,861 B2Grant

Edible PGA coating composition

Issue Date:2005-08-23

•12 Claims

Abstract

An edible, hardenable coating composition is disclosed which comprises high levels of low viscosity propylene glycol alginate and a surfactant, which may additionally contain a filler, a pigment and optionally a small amount of a secondary film former and/or a strengthening polymer. The coating composition of the present invention may be applied to pharmaceutical and veterinary solid dosage forms, confectionery, seeds, animal feed, fertilizers, pesticide tablets, and foods and provides an elegant prompt release coating which does not retard the release of active ingredients from the coated substrate.

Metadata

Assignee

FMC Corporation

Inventor

Michael Augello

Application Information

Application Number:US 10/077,338

Filing Date:2002-02-15

Priority Date:2000-11-28

Art Unit:1755

Patent Drawings

This patent does not have any drawings.

Description

Cross Reference to Related Applications

[0001] This application is a continuation in part of U.S. patent application Ser. No. 09/994,252, filed Nov. 26, 2001 now U.S. Pat. No. 6,699,315, patented 2 Mar. 2004, which claims the benefit of U.S. Provisional Application No. 60/284,778, filed Apr. 19, 2001; U.S. Provisional Application No. 60/268,608, filed Feb. 14, 2001; and U.S. Provisional Application No. 60/253,406, filed Nov. 28, 2000.

Field of Invention

[0002] This invention relates to edible, hardenable prompt release coating compositions comprising a film forming amount of low viscosity propylene glycol alginate that serves as the principle, primary or sole film former of the coating composition. The coatings of the present invention can be applied to pharmaceutical, including neutraceutical, and veterinary solid dosage forms, such solid substrates such as seeds, animal feed, fertilizers, pesticide tablets and granules, and also to confectionery and foods. They are readily dispersed in aqueous media, and, when applied as a coating, provide high lustre coatings which do not retard or extend release of active ingredient from a coated substrate.

Background of the Invention

[0003] It is a common practice to coat pharmaceutical and veterinary tablets to obtain several advantages. Among these are to improve the surface characteristics of tablets to make them easier to swallow, to reduce the absorption of water or moisture which can potentially degrade the active ingredient or promote some other undesirable change in the tablet structure, and simply to make a more elegant appearing tablet.

[0004] Another very important function of a pharmaceutical or veterinary tablet coating is to improve the integrity of the tablet itself. Uncoated tablets are often subject to being abraded or chipped, causing a loss of active ingredient in the process. More dramatically, they may break into two or more pieces. One measure of a useful coating is its ability to prevent any of these physical degradations of tablet structure. The effectiveness of a coating material to prevent abrading, chipping, or breakage of the tablet is determined by friability testing.

[0005] Confectionery and foods may be coated with a formulation to preserve the confection or food from deteriorating by contact with the oxygen and the moisture in the atmosphere. Coatings also can provide improved appearance and desirable organoleptic properties to the food as well as preventing loss of flavor.

[0006] Seeds may be coated to preserve the viability of the seeds by protecting against moisture. They may also be coated as a means for increasing particle size to facilitate mechanical planting. A dye can be included in the coating formulation to identify the seeds as to quality, type, or some other designation. Frequently, a pesticide, e.g., a fungicide, is incorporated into the coating formulation to protect both the seed itself and the seedling that results from germination of the seed. In all cases, this coating must not decrease the viability of the seeds or interfere with germination when the seeds are planted in the soil.

[0007] Animal feed may be coated to improve its flowability, appearance and its resistance to powdering or dusting. In such applications, the coating may be formulated to include vitamins, hormones, antibiotics, or the like, to benefit the livestock which will consume the feed.

[0008] Fertilizers, in either granular or tableted forms, may be coated to retain the integrity of the form and, especially, to protect the fertilizer from moisture which can cause agglomeration during storage, which could make rapid, even application to the soil difficult or inconvenient.

[0009] Coating of tableted pesticide formulations serves to maintain the integrity of the tablets or granules until they are placed in water where they rapidly disintegrate, forming a solution or slurry to be applied to the soil or plants. A second, and equally important, function of the coatings on tablets containing pesticides is to prevent human contact with the pesticide, thereby increasing safety for those handling and applying the pesticide.

[0010] In the preparation of a coating formulation to be sprayed, the film former is usually dissolved or dispersed in a solvent, for example, water, along with the other ingredients of the formulation. In aqueous systems, since many polymers require significant time to become fully hydrated, the coating formulation must frequently be prepared in advance of the time it is to be applied to the tablets. A common procedure is to prepare these coating formulations the day preceding the coating operation in order to assure adequate hydration of the polymers used in them.

[0011] A particular disadvantage of coatings based primarily on HPMC is that the coating may harden over time and therefore increase tablet disintegration times. An increase in disintegration time delays the bioavailability of the active ingredient at least in proportion to the increase in disintegration time. Many other agents commonly used in coating compositions are also known to delay release of pharmaceutical agents, such as enteric coatings which use polymeric film forming materials which are insoluble in water, or gastric fluid, some of these being specifically selected to by-pass both the stomach and small intestine and provide colonic-release.

[0012] The coatings of this invention meet U.S. Pharmacopoeia standards for rapid or immediate dissolution (U.S.P. monograph 23) of active ingredients from tablets or other solid dosage forms coated with them. They provide prompt release or dissolution consistent with the release rates which is normally obtained with the uncoated tablets or other substrates. Thus, they do not adversely impact or retard release of active ingredients from a substrate coated with them. Further, the coatings of this invention are readily dispersed and rapidly hydrated in aqueous media for application to a coating substrate, and provide elegant coatings which have all the benefits of coatings now in commercial use without the drawbacks that are common to them.

Summary of the Invention

[0013] It has been found that these and other advantages may be achieved in accordance with the present invention by a coating composition which comprises a low viscosity propylene glycol alginate as the principle or only film-forming component of the coating composition, preferably in combination with a surface active agent. The coating composition of the present invention utilizes as the primary film former a low viscosity propylene glycol alginate (PGA), a 1% aqueous solution of which has a viscosity in the range of about 1 to 500 mPa·s at 25° C. The PGA preferably is used in combination a surface active agent, and optionally such additional ingredients as a filler, a coloring agent, or combination of these, and may also contain a small amount of a secondary film former and/or a strengthening polymer as an additional ingredient. More specifically, the present invention provides a prompt release, edible, hardenable PGA coating composition, as well as dry coatings and aqueous dispersions thereof and solid dosage forms coated therewith.

Detailed Description of the Invention

[0014] For purposes of this application, the term “edible” is intended to mean food or pharmaceutical grade materials which are approved by regulatory authorities for use in pharmaceutical or food applications. The term “hardenable,” used to describe the coating compositions of this invention, is intended to include only those coating compositions that are capable of being dried from an aqueous solution or dispersion thereof into a solid coating which resists abrasive forces, i.e. a hardened coating, as distinguished from those “enrobing” coatings on confections which set up into a soft coating that can be handled and packaged but which do not resist abrasive forces significantly. The terms “immediate,” “rapid,” or “prompt,” as applied to dissolution rates or times for the coating compositions of this invention or tablets coated with the compositions of this invention, mean that the coatings of this invention meet U.S. Pharmacopoeia standards (U.S.P. monograph 23) for rapid or immediate dissolution of active ingredients from tablets or other solid dosage forms coated with them. Thus, they provide prompt release or dissolution consistent with the release rates which is normally obtained with the uncoated tablets or other substrate. They do not, when placed in water or ingested, adversely impact or retard release or dissolution of tablets or other dosage forms coated with them. Coatings made in accordance with the present invention are substantially or completely disintegrated and/or dissolved within less than 10 minutes after being ingested or placed in aqueous media. These definitions are intended to apply throughout this application unless a contrary meaning is clearly indicated.

[0015] Propylene glycol alginate provides important film-forming characteristics required to provide an elegant coating which is particularly useful in, for example, coating pharmaceutical and veterinary tablets, caplets, granules, and spheres which contain active ingredients which require release promptly after being placed in aqueous media or ingested.

[0016] Propylene glycol alginate by itself is known to be a film forming hydrocolloid when an aqueous dispersion thereof is spread on a surface and allowed to dry. However, the film has heretofore been considered to be too weak for satisfactory coatings. However, when a low viscosity propylene glycol alginate is utilized in high concentrations in combination with a suitable surface active agent, elegant, high performance coating formulations are provided which may readily be applied as an aqueous suspension to coating substrates. The propylene glycol alginate used in the present invention is a low viscosity propylene glycol alginate which, when present at 1% in water at 25° C. produces a aqueous solution having a viscosity in the range of about 1 to 500 mPa·s. It has been found that PGA having a viscosity substantially above about 500 mPa·s is difficult to formulate into suitable coatings, requires numerous additives to produce satisfactory coatings, and tend to be too viscous for practical application to materials to be coated. Low viscosity propylene glycol alginate is commercially available as Profoam® from Pronova and as Duckloid SLF-3 from Kibun. The low viscosity propylene glycol alginate is employed in the coating compositions at about 55% to about 100% by dry weight of the composition, more specifically at about 55% to about 85% by dry weight of the composition. In another embodiment of the invention, the low viscosity propylene glycol alginate is employed in the coating compositions at about 91% to about 100% by dry weight of the composition.

[0017] Surfactants which are either anionic or nonionic may be used beneficially in the edible, hardenable coating compositions of the present invention. Useful surfactants may be, for example, sodium lauryl sulfate, hydroxylated soy lecithin (lecithin), polysorbates, and block copolymers of propylene oxide and ethylene oxide. Such surface active agents may be employed at up to about 10% by dry weight of the composition. Surfactants such as lecithin assist in redispersion of the dry composition and improving flowability of the coating composition during application, assuring a smooth even coating.

[0018] In addition to PGA and a surface active agent, the balance of the composition may comprise certain adjuvants which are commonly utilized in coating compositions, including fillers and/or pigments for colored coatings, and may include a minor amount of secondary film former such as carrageenan or HPMC and/or a strengthening polymer such as hydroxyethylcellulose.

[0019] Fillers suitable for use in the compositions of the invention include, for example, calcium carbonate, dicalcium phosphate and carbohydrates, such as starch, maltodextrin, lactose, mannitol and other sugars, croscarmellose sodium, or microcrystalline cellulose. Of these, maltodextrin has been found beneficial at about 10% to about 30% by dry weight of the composition, but the other fillers may be used at these levels.

[0020] Coloring agents and opacifiers may be used in these coating compositions or added to a suspension thereof, including aluminum lakes, insoluble pigments, water-soluble dyes, titanium dioxide, and talc. Such coloring agents may be suitably employed at about 5% to about 15% by dry weight of the composition. In general such coloring agents may be utilized in addition to or in lieu of a filler. As further illustrated in the examples below, the combined amount of filler and coloring agent may suitably be in the range of about 10% to about 40% by dry weight of the composition.

[0021] It is also contemplated that certain other additives may be included in or added to the compositions of this invention. Depending on the amount of PGA present in the specific formulation, it may be desirable to include a secondary film former such as carrageenan and/or a strengthening polymer such as hydroxyethylcellulose. While such additional additives are generally not required, they may be utilized if desired at about 3% to about 12% by dry weight of the composition. A small amount stearic acid or a salt or ester thereof, and/or a conventional plasticizer may also be included at these levels to increase gloss elasticity of the coating. Suitable plasticizers include, for example, polyethylene glycol, triacetin, dibutyl sebacate, propylene glycol, sorbitol, glycerin, and triethyl citrate.

[0022] A coating formulation of this invention may be sold as a dry powder formulation or as a ready-to-use dispersion in water. For aqueous dispersions it is preferred that these be prepared under aseptic conditions. Heating the water to an elevated temperature, for example, 85° C., prior to preparation of the dispersion has shown that bacteria, mold, and yeast growth are prevented for at least 48 hours on agar pour plates. Therefore, if the containers for the dispersion are properly sanitized and then kept closed after being filled until the dispersion is used, there is little likelihood of bacteria, mold, or yeast growing in the dispersion. Alternatively, if a formulation is to be sold as an aqueous dispersion to be stored for a period of time, a preservative may be added. A combination of methyl paraben and propyl has been found to be useful in this regard.

[0023] On a dry weight percentage basis, one embodiment of the composition of this invention comprises from 60% to 85% of said propylene glycol alginate, 2% to 10% lecithin, and 10% to 30% maltodextrin. A second embodiment comprises from about 60% to 85% of propylene glycol alginate, 2% to 10% lecithin, and 5% to 15% pigment. Either embodiment may further comprise from 3% to about 12% by dry weight of the composition of a secondary film forming polymer such as carrageenan or a strengthening polymer such as hydroxyethylcellulose. Preservatives, such as methyl paraben at 0.75% to 1.50% and/or propyl paraben at 0.075% to 0.15% may also be present in the formulation.

[0024] The viscosity of the hydrated formulation can be important. It ideally should be low enough to be pumped to a spray unit continuously and then sprayed evenly in a useful pattern onto the substrate being coated. A useful concentration of the dry ingredients in water on a weight percentage basis, therefore, may be about 6% to about 15%, advantageously 6.5% to 11%, preferably about 8% to about 11%. To assure uniformity of the coating composition, it may be preferable to maintain agitation of the aqueous dispersion during the entire period of its being sprayed onto the pharmaceutical or veterinary solid dosage forms, confectionery, seeds, animal feed, fertilizer, pesticide tablets, or food.

[0025] The preferred edible, hardenable, prompt release coating formulations of this invention may generally be prepared and used according to a simple procedure. Propylene glycol alginate and other dry ingredients, including, as appropriate for the desired composition, a surface active agent, a filler, a secondary polymer, and/or preservatives, are dry blended together to a form dry coating composition. Addition of edible coloring agents, for example, a water-soluble dye or a pigment, may precede the hydration step required to prepare the final coating formulation. This dry mixture is then added slowly to the vortex of stirred, purified water. Stirring of this mixture is continued for a sufficient period to allow all of the components to be fully hydrated. If a colored coating material is required a water soluble dye or a pigment may also be added, preferably as a dispersion or solution, to the hydrated coating composition. Optionally surfactants, and/or plasticizers may also be added at this stage of the process.

[0026] In the hydration step, a simple propeller mixer provides adequate agitation for rapid hydration. The period of hydration may be as short as 0.5 hours. It may, and preferably should, be longer, but more than 3 hours is not believed to be necessary. Hydration can take place at room temperature or at elevated temperatures as high as 65.5° C. (150° F.), preferably at a temperature about 48.9° C. (120° F.). The time required for full hydration and the viscosity of the dispersion are both considerably reduced when the dispersion is prepared at an elevated temperature, but coating dispersions prepared at ambient temperature only require an increase in hydration time and a slight reduction in solids content to perform completely satisfactorily. As previously stated, these formulations may be prepared on the day preceding the coating operation, if that is more convenient; however, a period of mixing will be required to overcome any thixotropic behavior of a formulation which sets up during overnight storage. Unlike coating formulations based primarily on hydroxyalkyl ethers of cellulose, for example, HPMC, constant stirring of the propylene glycol alginate-based formulations of this invention does not need to be continued throughout the coating procedure, but mixing may continue, if preferred.

[0027] Any commercial spray coater may be used to apply the coating. Examples of useful coaters are Vector High Coaters manufactured by Vector Corporation and Accela-Coat manufactured by Thomas Engineering. Equipment variables which one skilled in the art can manipulate to provide an elegant coating based on propylene glycol alginate, include inlet temperature, outlet temperature, air flow, speed of rotation of the coating pan, and the rate at which the coating formulation is pumped to the coater. It is important that the inlet and outlet temperatures be controlled so that they are high enough to efficiently dry the coating to prevent the tumbling action of the already-coated tablets from damaging the newly-applied coating before more coating is applied to the same tablets.

[0028] The level of coating applied to pharmaceutical or veterinary dosage forms is preferably between about 0.5% to about 4% by weight of the uncoated dosage form, more preferably about 2% to about 3.5%, by weight of the uncoated dosage form. This level of coating will provide an elegant, serviceable coating to a wide variety of dosage forms. To apply a heavier coating to tablets would not be economical, and it might adversely affect disintegration of the tablets or other properties. Too light a coating would not provide optimal properties normally expected from a coating.

[0029] For confections the coating level should be about 5% to about 10% by weight of the uncoated confection. Seed coatings should be in the range of about 3% to about 6% by weight of the uncoated seeds. Fertilizers and pesticide tablets and granules benefit from coating of 1% to about 3%, by weight of the uncoated granules or tablets.

[0030] The coatings of the present invention may be applied successfully to tablets having wide variety of active ingredients incorporated therein. For example, it has been reported that multivitamin tablets are difficult to coat because of the lipophilic surface properties of the vitamins. Similarly, ibuprofen is a challenging active ingredient to coat. Tablets comprising both of these difficult-to-coat active ingredients may be readily coated with the coating compositions of this invention, providing elegant tablets. Additionally, the coating have been applied to tablets which have been debased with letters or a logo without bridging which would hide, or even obliterate, the debossed design.

[0031] Storage of coated tablets under ambient temperature and humidity and 40° C. and 75% relative humidity for one to three months has demonstrated that no significant degradation has occurred. These tablets have disintegrated within the same length of time as the same batch of newly coated tablets did, and in each case provided dissolution-rates and times substantially equal to those of the uncoated tablets used as a substrate for coating. This is an additional unexpected benefit of the coatings based on propylene glycol alginate.

[0032] All components of the formulation are typically pharmaceutically acceptable, edible food grade materials.

[0033] The following examples, in which percentages are weight percent, are provided to demonstrate the method of preparation and application of these elegant coatings, but they are not intended to be limiting as to amounts and the type of optional ingredients or the specific method of application of the tablet coating described herein.

Example 1

[0034] In a Patterson-Kelly twin shell blender were placed 250 grams of low viscosity propylene glycol alginate (Profoam, Pronova/FMC Corporation) and 10 grams of hydroxylated soy lecithin (Precept 8120, Central Soya). After the dry components had been thoroughly blended, the blend was added slowly to the vortex of 3450 grams deionized water which was stirred with a Lightnin' mixer. The suspension was stirred for 3 hours at ambient temperature to fully hydrate the composition. To this dispersion was added 40 grams of Chroma-Kote red liquid dispersion (Crompton and Knowles). A 24″ Acella Comp-U-Coat coater was charged with 12 Kg of ibuprofen caplets. The coater was operated at an inlet temperature of 40-55° C., an outlet temperature of 35-39° C., and 8-9 rpm. During the spraying, which required 85 minutes, a 2-3% by weight coating, based on the weight of the caplets, was applied. The composition of the coating and the physical properties of the coated caplets are shown as Example 1 of Table 1, below.

Examples 2 and 3

[0035] In a Patterson-Kelly twin shell blender were placed 292 grams of low viscosity propylene glycol alginate (Profoam, Pronova/FMC Corporation) and 45 grams of hydroxyethylcellulose 250L, 22.5 grains of hydroxylated soy lecithin (Precept 8120, Central Soya), 45 grams of maltodextrin Ml 80 (Maltrin Ml 80, GPC) and 45 grams of Color Blend Pigment (Croma-tone, Warner Jenkinson). After the dry components had been thoroughly blended, the blend was added slowly to the vortex of 5175 grains deionized water which was stirred with a Lightnin' mixer. The suspension was stirred for 2 hours at ambient temperature to fully hydrate the composition. To this dispersion was added 40 grams of Chroma-Kote red liquid dispersion (Crompton and Knowles). A 24″ Acella Comp-U-Coat coater was charged with 12 Kg of ibuprofen caplets. The coater was operated at an inlet temperature of 53-55° C., an outlet temperature of 32-39° C., and 8-11 rpm. During the spraying, which required 63-69 minutes, a 3% by weight coating, based on the weight of the caplets, was applied. The composition of the coating and the physical properties of the coated caplets are shown as Example 2 and 3 of Table 1, below.

Example 4

[0036] In a Patterson-Kelly twin shell blender were placed 65 grams of low viscosity propylene glycol alginate (Profoam, Pronova/FMC Corporation), 22.5 grams of hydroxylated soy lecithin (Precept 8120, Central Soya), and 45 grams of maltodextrin Ml 80 (Maltrin Ml 80, GPC). After the dry components had been thoroughly blended, the blend was added slowly to the vortex of 1150 grams deionized water which was stirred with a Lightnin' mixer. The suspension was stirred for 2 hours at ambient temperature to fully hydrate the composition. A Vector LDCD 15″ coater was charged with 2 Kg of chlorpheniramine 4 mg tablets. The coater was operated at an inlet temperature of 74-83° C., an outlet temperature of 34-39° C., and 13-16 rpm. During the spraying, which required 67 minutes, a 3% by weight coating, based on the weight of the caplets, was applied. The composition of the coating and the physical properties of the coated caplets are shown as Example 4 of Table 1, below.

Example 5

[0037] In a Patterson-Kelly twin shell blender were placed 270 grams of low viscosity propylene glycol alginate (Profoam, Pronova/FMC Corporation), 11.25 grams of hydroxylated soy lecithin (Precept 8120, Central Soya), and 135 grains of maltodextrin M180 (Maltrin M180, GPC), and 33.75 grams of Pigment Blend (Chroma-tone, Warner Jenkinson). After the dry components had been thoroughly blended, the blend was added slowly to the vortex of 5175 grams deionized water which was stirred with a Lightnin' mixer. The suspension was stirred for 2 hours at ambient temperature to fully hydrate the composition. A Vector LDCD 15″ coater was charged with 2 Kg of acetaminophen 500 mg caplets. The coater was operated at an inlet temperature of 52-54° C., an outlet temperature of 32-37° C., and 8-10 rpm. During the spraying, which required 63 minutes, a 3% by weight coating, based on the weight of the caplets, was applied. The composition of the coating and the physical properties of the coated caplets are shown as Example 5 of Table 1, below.

Example 6

[0038] In a Patterson-Kelly twin shell blender were placed 247.5 grams of low viscosity propylene glycol alginate (Profoam, Pronova/FMC Corporation), 22.5 grams of hydroxylated soy lecithin (Precept 8120, Central Soya), and 112.5 grams of maltodextrin Ml 80 (Maltrin Ml 80, GPC), 22.5 grams sodium iota carrageenan (FMC Corporation), and 33.75 grams of Pigment (Whittaker, Clarke & Daniels). After the dry components had been thoroughly blended, the blend was added slowly to the vortex of 5175 grams deionized water which was stirred with a Lightnin' mixer. The suspension was stirred for 4 hours at ambient temperature to fully hydrate the composition. A 24″ Accela Comp-U-Coat coater was charged with 2 Kg of acetaminophen 500 mg caplets. The coater was operated at an inlet temperature of 52-53 OC, an outlet temperature of 33-35° C., and 9-12 rpm. During the spraying, which required 4 hours, a 3% by weight coating, based on the weight of the caplets, was applied. The composition of the coating and the physical properties of the coated caplets are shown as Example 6 of Table 1, below.

[0039]

TABLE 1

Example
1	2	3	4	5	6

Ingredients	(% by dry weight)
PGA¹	83.3	65	65	65	60	55
Lecithin²	3.3	5	7	5	2.5	5
Maltodextrin³	—	10	18	30	30	25
Pigment	13.4	10	10	—	7.5	10
HEC⁴	—	10	—	—	—	—
Iota carrageenan	—	—	—	—	—	5
Caplet Ingredients
Acetaminophen					X	X
Ibuprofen	X	X	X
Chlorpheniramine				X
Coating Weight	3	3	3	3	3	3
(%)
Friability (10	0%	0%	0%	0%	0%	0%
minutes)
Appearance	5	5	5	5	5	5
(shine)⁵
Initial Dissolution	(% @ Time)
15 minutes	NT⁶	31	34	89	NT	NT
30 minutes		69	71	100
45 minutes		92	91
60 minutes		99	99

¹Polypropylene glycol alginate (Profoam ®, Pronova/FMC Corporation)
²Hydroxylated soy lecithin, Central Soya
³Maltodextrin, Maltrin M180
⁴Hydroxyethylcellulose 250 L
⁵5 = excellent; 4 = acceptable; 3 = marginal; 2 = poor; 1 = Not acceptable
⁶Not tested

Example 7

[0040] In a Patterson-Kelly twin shell blender were placed 90 grams of low viscosity propylene glycol alginate (Duckloid SLF-3, Kibun) and 10.00 grams of (Red Iron Oxide, hydrophillic, WCD). After the dry components had been thoroughly blended, the blend was stirred with a Lightnin' mixer. The suspension was stirred for 4.5 hrs. at an ambient temperature to fully hydrate the composition. A 15″ vector LDCS loader was charged with 1.9 kilograms of Acetaminophen 500 milligram caplets. The coater was operated at an inlet temperature of 74-75° C. An outlet temperature of 34-35° C. and 14-16 RPM. During the spraying, which required 55 minutes, a 3% by weight coating, based on the weight of the caplets, was applied. The composition of the coating and the physical properties of the coated caplets are shown as example 7 of Table 2 below.

Example 8

[0041] In a Patterson-Kelly twin shell blender were placed 80 grams of low viscosity propylene glycol alginate (Duckloid SLF-3, Kibun), 17 grams of polyethylene glycol 8000 (PEG 8000, Union Carbide) and 3.00 grams of Maltodextrin-180 (Maltrin-M-180, Grain Processing Corporation). After the dry components had been thoroughly blended, the blend was added slowly to the vortex of 900.0 grams deionized water which was stirred with a Lightnin' Mixer. The suspension was stirred for 1 hour at an ambient temperature to fully hydrate the composition. A 15″ Vector LDCS coater was charged with 2.0 kilograms of Acetometaphin. A 15″ Vector LDCS coater was charged with 2.0 kilograms of Acetaminophen 500 milligram caplets. The coater was operated at an inlet temperature of 73-78° C., an outlet temperature of 34-39° C., and 13 RPM. During the spraying, which required 57 minutes, a 3% by weight coating, based on the weight of the caplets, was applied. The composition of the coating and physical properties of the coated caplets are shown as Example 8 of Table 2, below.

Example 9

[0042] In a Patterson-Kelly twin shell blender were placed 80.82 grams of low viscosity propylene glycol alginate (Duckloid SLF-3, Kibun), 10.1 grams of Lactose Anhydrous (Sheffield Corporation) and 9.1 grams of Blue Pigment Blend (Chromatone, Warner Jenkinson). After the dry components had been thoroughly blended, the blend was added slowly to the vortex of 1011.0 grams deionized water which was stirred with a Lightnin' Mixer. The suspension was stirred for 1 hour and 45 minutes to fully hydrate the composition. A 15″ Vector LDCD was charged with 2.0 Kilograms of Ibuprofen 200 milligram caplets. The coater was operated at an inlet temperature of 66-72° C., an outlet temperature of 32-35° C. and 12-16 RPM. During the spraying, which required 1 hour and 2 minutes, a 3% by weight coating, based on the weight of the caplets, was applied. The composition of the coating and the physical properties of the coated caplets are shown as Example 9 of Table 2, below.

Example 10

[0043] In a Patterson-Kelly twin shell blender were placed 65.0 grams of low viscosity propylene glycol alginate (Duckloid SLF-3, Kibun) and 35.0 grams of Polyethylene glycol 8000 (PEG 8000, Union Carbide). After the components had been thoroughly blended, the blend was added slowly to the vortex of 1011.0 grams deionized water which was stirred with a Lightnin' Mixer. The suspension was stirred for 1 hour at an ambient temperature to fully hydrate the composition A 15″ Vector LDCD coater was charged with 1.9 kilograms of acetaminophen 500 milligram caplets. The coater was operated at an inlet temperature of 73-78° C., an outlet temperature of 32-35° C. and 12-17 RPM. During the spraying, which required 54 minutes, a 3% by weight coating, based on the weight of the caplets, was applied. The composition of the coating and the physical properties of the coated caplets are shown by Example 10 of Table 2, below.

Example 11

[0044] In a Patterson-Kelly twin shell blender were placed 85.0 grams of low viscosity propylene glycol alginate (Duckloid SLF-3, Kibun), 5.00 grams of Lactose Anhydrous (Sheffield Corporation) and 10.0 grams of Yellow Lake Blend (Warner Jenkinson). After the dry components had been thoroughly blended, the blend was added slowly to the vortex of 1011.0 grams deionized water which was stirred with a Lightnin' Mixer. The suspension was stirred for 1 hour to fully hydrate the composition. A 15″ Vector LDCD was charged with 1.9 kilograms of Acetaminophen 500 milligram caplets. The coater was operated at an inlet temperature of 77-80° C., an outlet temperature of 33-36° C. and 13-17 RPM. During the spraying, which required 53 minutes, a 3% by weight coating, based on the weight of the caplets, was applied. The composition of the coating and the physical properties of the coated caplets are shown as Example 11 of Table 2, below.

[0045]

	TABLE 2

	Example
	7	8	9	10	11

Ingredients	(% by dry weight)
PGA¹	90.0	80	80.82	65.0	85
Maltodextrin²	—	3.0	—	—	—
Pigment³	10.0	—	9.1	—	10.0
PEG 8000⁴	—	17.0	—	35.0	—
Lactose	—	—	10.1	—	5.0
Anhydrous⁵
Caplet Ingredients
Acetaminophen	X	X		X	X
Ibuprofen			X
Coating Weight	3	3	3	3	3
(%)
Friability (10	0%	0%	0%	0%	0%
minutes)
Appearance	5	5	5	5	5
(shine)⁶
Initial
Dissolution	(% @ Time)
10 minutes	87.0%	86%	N/A	N/A	N/A
15 minutes	N/A	N/A	50.0%	N/A	N/A
20 minutes	99.0%	97.0	N/A	N/A	N/A
30 minutes	101.0%	99.0%	84.0%	N/A	N/A
45 minutes	N/A	N/A	96.0%	N/A	N/A
60 minutes	N/A	N/A	99.0%	N/A	N/A

¹Polypropylene glycol alginate (Duckloid SLF-3, Kibun) (Spectrum Chem, USP/NF)
²Maltodextrin, Maltrin M180
³Pigment (Whittaker Clarke & Daniels, Warner Jenkinson)
⁴Polyethylene Glycol 8000 (Union Carbide)
⁵Lactose Anhydrous (Sheffield)
⁶5 = excellent; 4 = acceptable; 3 = marginal; 2 = poor; 1 = Not acceptable

Claims

1. A solid dosage form coated with an edible, hardenable, prompt release coating composition comprising 55% to 85% of propylene glycol alginate and up to 10% of a surfactant, wherein the propylene glycol alginate is a primary film former of the composition and such that a 1% aqueous solution thereof has a viscosity in the range of about 1 to 500 mPa·s at 25° C.

2. The solid dosage form of claim 1, wherein said solid dosage form is a pharmaceutical or veterinary tablet.

3. The solid dosage form of claim 1, wherein said coating composition is about 0.5% to about 4% by weight of said uncoated solid dosage form.

4. An edible, hardenable, prompt release coating composition comprising:

at least one of a filler and a pigment, the filler being maltodextrin; and

55% to 85% of propylene glycol alginate and up to 10% lecithin, wherein the propylene glycol alginate is a primary film former of the composition and such that a 1% aqueous solution thereof has a viscosity in the range of about 1 to 500 mPa·s at 25° C.

5. The coating composition of claim 4, wherein the combination of the filler and the pigment comprises 10% to 40% by dry weight of the composition.

6. An edible, hardenable, prompt release coating composition comprising:

at least one of a filler and a pigment, the pigment forming from 5% to 15% of the composition; and

7. The coating composition of claim 6, wherein the combination of the filler and the pigment comprises 10% to 40% by dry weight of the composition.

8. An edible, hardenable, prompt release coating composition comprising 55% to 85% of propylene glycol alginate, 10% to 30% maltodextrin, and 2% to 10% lecithin, wherein the propylene glycol alginate is a primary film former of the composition and such that a 1% aqueous solution thereof has a viscosity in the range of about 1 to 500 mPa·s at 25° C.

9. The coating composition of claim 8, further comprising from 3% to 12% of a secondary film former or a strengthening polymer.

10. The coating composition of claim 9 wherein carrageenan is present at 5% to 10% by dry weight of the composition.

11. The coating composition of claim 9 where hydroxyethylcellulose is present at 5% to 10% by dry weight of the composition.

12. An edible, hardenable, prompt release coating composition comprising 55% to 85% of propylene glycol alginate, 5% to 15% pigment, and 2% to 10% lecithin, wherein the propylene glycol alginate is a primary film former of the composition and such that a 1% aqueous solution thereof has a viscosity in the range of about 1 to 500 mPa·s at 25° C.

Patent Citations (338)

Patent	Date	Inventor	Cited By
US2134714(A)	1938-11-01	Glassman	Applicant
US2881085(A)	1959-04-01	Endicott et al.	Applicant
US3149039(A)	1964-09-01	Jeffries	Applicant
US3149040(A)	1964-09-01	Jeffries	Applicant
US3297535(A)	1967-01-01	Butler et al.	Applicant
US3407157(A)	1968-10-01	Carstensen et al.	Applicant
US3438797(A)	1969-04-01	Biddle, Sr.	Applicant
US3503769(A)	1970-03-01	McDowell	Applicant
US3573058(A)	1971-03-01	Tieninstra et al.	Applicant
US3576663(A)	1971-04-01	Signorino et al.	Applicant
US3649302(A)	1972-03-01	Daggy et al.	Applicant
US3751277(A)	1973-08-01	Small et al.	Applicant
US3835221(A)	1974-09-01	Fulberth et al.	Applicant
US3851574(A)	1974-12-01	Katz et al.	Applicant
US3860733(A)	1975-01-01	Morse et al.	Applicant
US3873694(A)	1975-03-01	Kanig	Applicant
US3883458(A)	1975-05-01	Mueller et al.	Applicant
US3906086(A)	1975-09-01	Guy et al.	Applicant
US3906088(A)	1975-09-01	Trichot	Applicant
US3935326(A)	1976-01-01	Groppenbacher et al.	Applicant
US3957966(A)	1976-05-01	Valan	Applicant
US3981984(A)	1976-09-01	Signorino	Applicant
US4009131(A)	1977-02-01	Farone	Applicant
US4015999(A)	1977-04-01	Robertson et al.	Applicant
US4060598(A)	1977-11-01	Groppenbacher et al.	Applicant
US4095992(A)	1978-06-01	Rudolph et al.	Applicant
US4112215(A)	1978-09-01	Boessler et al.	Applicant
US4143163(A)	1979-03-01	Hutchison et al.	Applicant
US4250195(A)	1981-02-01	Cherukuri et al.	Applicant
US4252786(A)	1981-02-01	Weiss et al.	Applicant
US4257816(A)	1981-03-01	Yin et al.	Applicant
US4274830(A)	1981-06-01	Woznicki et al.	Applicant
US4287221(A)	1981-09-01	Tonedachi et al.	Applicant
US4292299(A)	1981-09-01	Suzuki et al.	Applicant
US4295851(A)	1981-10-01	Neumann et al.	Applicant
US4302440(A)	1981-11-01	John et al.	Applicant
US4307117(A)	1981-12-01	Leshik	Applicant
US4316884(A)	1982-02-01	Alam et al.	Applicant
US4324554(A)	1982-04-01	Racciato	Applicant
US4330338(A)	1982-05-01	Banker	Applicant
US4336244(A)	1982-06-01	Woznicki et al.	Applicant
US4340582(A)	1982-07-01	Kriesel et al.	Applicant
US4341563(A)	1982-07-01	Kurihara et al.	Applicant
US4375468(A)	1983-03-01	Dunn	Applicant
US4421738(A)	1983-12-01	Yamagiwa et al.	Applicant
US4432966(A)	1984-02-01	Zeitoun et al.	Applicant
US4475919(A)	1984-10-01	Woznicki et al.	Applicant
US4505890(A)	1985-03-01	Jain et al.	Applicant
US4513019(A)	1985-04-01	Brancq et al.	Applicant
US4514384(A)	1985-04-01	Gallina	Applicant
US4524060(A)	1985-06-01	Mughal et al.	Applicant
US4533562(A)	1985-08-01	Ikegami et al.	Applicant
US4543370(A)	1985-09-01	Porter et al.	Applicant
US4556552(A)	1985-12-01	Porter et al.	Applicant
US4576646(A)	1986-03-01	Branco et al.	Applicant
US4596602(A)	1986-06-01	Bennett	Applicant
US4636261(A)	1987-01-01	Heinze	Applicant
US4643894(A)	1987-02-01	Porter et al.	Applicant
US4645662(A)	1987-02-01	Nakashima et al.	Applicant
US4652313(A)	1987-03-01	Den Boer et al.	Applicant
US4661162(A)	1987-04-01	Kurihara et al.	Applicant
US4665648(A)	1987-05-01	Branco et al.	Applicant
US4666703(A)	1987-05-01	Kopf	Applicant
US4683256(A)	1987-07-01	Porter et al.	Applicant
US4693750(A)	1987-09-01	Bauer et al.	Applicant
US4693751(A)	1987-09-01	Den Boer et al.	Applicant
US4704295(A)	1987-11-01	Porter et al.	Applicant
US4720378(A)	1988-01-01	Forse et al.	Applicant
US4725441(A)	1988-02-01	Porter et al.	Examiner
US4750938(A)	1988-06-01	Cottrell	Applicant
US4784858(A)	1988-11-01	Ventouras	Applicant
US4786511(A)	1988-11-01	Huzinec et al.	Applicant
US4790881(A)	1988-12-01	Wittwer et al.	Applicant
US4792452(A)	1988-12-01	Howard et al.	Applicant
US4802924(A)	1989-02-01	Woznicki et al.	Applicant
US4814181(A)	1989-03-01	Jordan et al.	Applicant
US4816298(A)	1989-03-01	Alderman et al.	Applicant
US4828841(A)	1989-05-01	Porter et al.	Applicant
US4857337(A)	1989-08-01	Miller et al.	Applicant
US4859462(A)	1989-08-01	Chow et al.	Applicant
US4877629(A)	1989-10-01	Stypula et al.	Applicant
US4892741(A)	1990-01-01	Ohm et al.	Applicant
US4900557(A)	1990-02-01	Dell et al.	Applicant
US4910028(A)	1990-03-01	Bernacchi et al.	Applicant
US4913919(A)	1990-04-01	Cornwell et al.	Applicant
US4915954(A)	1990-04-01	Ayer et al.	Applicant
US4956193(A)	1990-09-01	Cain et al.	Applicant
US4959227(A)	1990-09-01	Amer	Applicant
US4981698(A)	1991-01-01	Cherukuri et al.	Applicant
US4981707(A)	1991-01-01	Morris	Applicant
US4983399(A)	1991-01-01	Maish	Applicant
US4994276(A)	1991-02-01	Baichwal et al.	Applicant
US5006513(A)	1991-04-01	Hector et al.	Applicant
US5008113(A)	1991-04-01	Kokubo et al.	Applicant
US5008117(A)	1991-04-01	Calanchi et al.	Applicant
US5009897(A)	1991-04-01	Brinker et al.	Applicant
US5023083(A)	1991-06-01	Drell	Applicant
US5024842(A)	1991-06-01	Edgren et al.	Applicant
US5047258(A)	1991-09-01	Belanger et al.	Applicant
US5059248(A)	1991-10-01	Signorino et al.	Applicant
US5068110(A)	1991-11-01	Fawzi et al.	Applicant
US5082684(A)	1992-01-01	Fung	Examiner
US5089270(A)	1992-02-01	Hampton et al.	Applicant
US5098715(A)	1992-03-01	McCabe et al.	Applicant
US5122385(A)	1992-06-01	Daher et al.	Applicant
US5128143(A)	1992-07-01	Baichwall et al.	Applicant
US5169642(A)	1992-12-01	Brinker et al.	Applicant
US5194464(A)	1993-03-01	Itoh et al.	Applicant
US5202129(A)	1993-04-01	Samejima et al.	Applicant
US5202137(A)	1993-04-01	Duffy et al.	Applicant
US5209942(A)	1993-05-01	Bauer et al.	Applicant
US5213738(A)	1993-05-01	Hampton et al.	Applicant
US5225202(A)	1993-07-01	Hodges et al.	Applicant
US5262173(A)	1993-11-01	Sheth et al.	Applicant
US5268182(A)	1993-12-01	Brinker et al.	Applicant
US5286502(A)	1994-02-01	Meyers	Applicant
US5286510(A)	1994-02-01	Bauer	Applicant
US5288501(A)	1994-02-01	Nurnberg et al.	Applicant
US5306506(A)	1994-04-01	Zema et al.	Applicant
US5310572(A)	1994-05-01	Woodard et al.	Applicant
US5332595(A)	1994-07-01	Gaonkar	Applicant
US5358990(A)	1994-10-01	Woodard et al.	Applicant
US5368840(A)	1994-11-01	Unger	Applicant
US5389129(A)	1995-02-01	Jordan	Applicant
US5393333(A)	1995-02-01	Trouve	Applicant
US5401515(A)	1995-03-01	Woodard et al.	Applicant
US5409715(A)	1995-04-01	Meyers	Applicant
US5411746(A)	1995-05-01	Signorino et al.	Applicant
US5429830(A)	1995-07-01	Janovsky et al.	Applicant
US5433960(A)	1995-07-01	Meyers	Applicant
US5435840(A)	1995-07-01	Hilborn	Applicant
US5458887(A)	1995-10-01	Chen et al.	Applicant
US5470581(A)	1995-11-01	Grillo et al.	Applicant
US5470603(A)	1995-11-01	Staniforth et al.	Applicant
US5472710(A)	1995-12-01	Klokkers-Bethke et al.	Applicant
US5472712(A)	1995-12-01	Oshlack et al.	Applicant
US5480479(A)	1996-01-01	Signorino	Applicant
US5512092(A)	1996-04-01	Maruyama et al.	Applicant
US5512314(A)	1996-04-01	Signorino et al.	Applicant
US5514384(A)	1996-05-01	Signorino	Applicant
US5514435(A)	1996-05-01	Suzuki et al.	Applicant
US5523293(A)	1996-06-01	Jane et al.	Applicant
US5529783(A)	1996-06-01	Burke et al.	Applicant
US5547948(A)	1996-08-01	Barcomb	Applicant
US5560930(A)	1996-10-01	Maruyama et al.	Applicant
US5580580(A)	1996-12-01	Masterson et al.	Applicant
US5591455(A)	1997-01-01	Signorino	Applicant
US5595592(A)	1997-01-01	Signorino et al.	Applicant
US5595762(A)	1997-01-01	Derrieu et al.	Applicant
US5629003(A)	1997-05-01	Horstmann et al.	Applicant
US5630871(A)	1997-05-01	Jordan	Applicant
US5656080(A)	1997-08-01	Staniforth et al.	Applicant
US5662732(A)	1997-09-01	Kelley et al.	Applicant
US5663198(A)	1997-09-01	Reul et al.	Applicant
US5683722(A)	1997-11-01	Derrieu et al.	Applicant
US5695784(A)	1997-12-01	Pollinger et al.	Applicant
US5700929(A)	1997-12-01	Kokubo et al.	Applicant
US5709896(A)	1998-01-01	Hartigan et al.	Applicant
US5733575(A)	1998-03-01	Mehra et al.	Applicant
US5741600(A)	1998-04-01	Olson	Applicant
US5743947(A)	1998-04-01	Jordan	Applicant
US5756123(A)	1998-05-01	Yamamoto et al.	Applicant
US5759576(A)	1998-06-01	Barcomb	Applicant
US5759577(A)	1998-06-01	Barcomb	Applicant
US5780057(A)	1998-07-01	Conte et al.	Applicant
US5840332(A)	1998-11-01	Lerner et al.	Applicant
US5849320(A)	1998-12-01	Turnblad et al.	Applicant
US5851579(A)	1998-12-01	Wu et al.	Applicant
US5876739(A)	1999-03-01	Turnblad et al.	Applicant
US5882707(A)	1999-03-01	Grillo et al.	Applicant
US5885617(A)	1999-03-01	Jordan	Applicant
US5904937(A)	1999-05-01	Augello et al.	Applicant
US6030641(A)	2000-02-01	Yamashita et al.	Applicant
US6039976(A)	2000-03-01	Mehra et al.	Applicant
US6153601(A)	2000-11-01	Breton et al.	Applicant
US6174529(B1)	2001-01-01	Michael et al.	Applicant
US6183808(B1)	2001-02-01	Grillo et al.	Examiner
US6228398(B1)	2001-05-01	Devane et al.	Applicant
US6267808(B1)	2001-07-01	Grillo et al.	Examiner
US6270830(B1)	2001-08-01	Kamada et al.	Applicant
US6274162(B1)	2001-08-01	Steffenino et al.	Applicant
US6326028(B1)	2001-12-01	Nivaggioli et al.	Applicant
US6348090(B1)	2002-02-01	Grillo et al.	Examiner
US6391368(B1)	2002-05-01	Tuason et al.	Applicant
DE2522483	1975-12-01		Applicant
DE2522493	1975-12-01		Applicant
DE2820981	1979-04-01		Applicant
DE3720757	1989-01-01		Applicant
DE3829942	1989-03-01		Applicant
DE3929184	1991-03-01		Applicant
EP63014	1985-08-01		Applicant
EP153104	1985-08-01		Applicant
EP171457	1986-02-01		Applicant
EP181650	1986-05-01		Applicant
EP197571(B1)	1986-10-01		Applicant
EP226671	1987-07-01		Applicant
EP20496	1988-01-01		Applicant
EP255725	1988-02-01		Applicant
EP256538	1988-02-01		Applicant
EP305051	1989-01-01		Applicant
EP339811	1989-11-01		Applicant
EP347748	1989-12-01		Applicant
EP347748	1989-12-01		Applicant
EP360562	1990-03-01		Applicant
EP222856	1990-12-01		Applicant
EP425154	1991-05-01		Applicant
EP434321	1991-06-01		Applicant
EP443572	1991-08-01		Applicant
EP453001	1991-10-01		Applicant
EP460185	1991-12-01		Applicant
EP525389	1992-06-01		Applicant
EP497331	1992-08-01		Applicant
EP527637	1993-02-01		Applicant
EP550737	1993-07-01		Applicant
EP595110	1993-10-01		Applicant
EP567541	1993-11-01		Applicant
EP600775	1994-06-01		Applicant
EP627173(A1)	1994-07-01		Applicant
EP630646	1994-12-01		Applicant
EP648487	1995-04-01		Applicant
EP663820	1995-07-01		Applicant
EP684042	1995-11-01		Applicant
EP707475	1996-04-01		Applicant
EP714656	1996-06-01		Applicant
EP737472	1996-10-01		Applicant
EP746310	1996-12-01		Applicant
EP751837	1997-01-01		Applicant
EP788790	1997-08-01		Applicant
EP795324	1997-09-01		Applicant
EP829478(A2)	1998-03-01		Applicant
EP839527	1998-05-01		Applicant
EP852141	1998-07-01		Applicant
EP245855	1999-01-01		Applicant
EP592130	1999-04-01		Applicant
EP974366	2000-01-01		Applicant
EP1010423	2000-06-01		Applicant
EP1101490	2001-05-01		Applicant
FR2404029	1979-04-01		Applicant
FR2404029	1979-04-01		Applicant
GB734414	1956-01-01		Applicant
GB1371840	1974-10-01		Applicant
GB1594102	1977-09-01		Applicant
GB1581841	1980-12-01		Applicant
GB5594102	1987-07-01		Applicant
GB2212396	1989-07-01		Applicant
JP51123815	1975-04-01		Applicant
JP52117413	1976-03-01		Applicant
JP118057	1982-05-01		Applicant
JP1774819	1985-03-01		Applicant
JP5-29205	1985-10-01		Applicant
JP6132289	1986-07-01		Applicant
JP6-62400	1987-05-01		Applicant
JP62-111917	1987-05-01		Applicant
JP118057	1989-04-01		Applicant
JP2134366	1995-03-01		Applicant
JP8109126	1996-04-01		Applicant
JP2646851	1997-05-01		Applicant
JP11315032	1999-02-01		Applicant
JP1160472	1999-03-01		Applicant
JP11116467	1999-04-01		Applicant
JP11315032	1999-11-01		Applicant
WO84/02843	1984-08-01		Applicant
WO85/01207	1985-03-01		Applicant
WO86/06626	1986-11-01		Applicant
WO88/01506	1988-03-01		Applicant
WO88/03795	1988-06-01		Applicant
WO90/11754	1990-10-01		Applicant
WO9114729	1991-10-01		Applicant
WO91/15548	1991-10-01		Applicant
WO9209273	1992-06-01		Applicant
WO92/11002	1992-07-01		Applicant
WO92/15288	1992-09-01		Applicant
WO93/15719	1993-08-01		Applicant
WO93/19061	1993-09-01		Applicant
WO9320711	1993-10-01		Applicant
WO93/25238	1993-12-01		Applicant
WO94/03160	1994-02-01		Applicant
WO95/08993	1995-04-01		Applicant
WO95/11667	1995-05-01		Applicant
WO9522962	1995-08-01		Applicant
WO95/22962	1995-08-01		Applicant
WO9528918	1995-11-01		Applicant
WO9601874	1996-01-01		Applicant
WO96/10995	1996-04-01		Applicant
WO96/16664	1996-06-01		Applicant
WO96/29058	1996-09-01		Applicant
WO96/30011	1996-10-01		Applicant
WO96/33700	1996-10-01		Applicant
WO96/35413	1996-11-01		Applicant
WO96/35516	1996-11-01		Applicant
WO97/02038	1997-01-01		Applicant
WO97/09967	1997-03-01		Applicant
WO97/15191	1997-05-01		Applicant
WO97/18839	1997-05-01		Applicant
WO97/23564	1997-07-01		Applicant
WO97/34580	1997-09-01		Applicant
WO9737638	1997-10-01		Applicant
WO97/49301	1997-12-01		Applicant
WO98/06250	1998-02-01		Applicant
WO98/17126	1998-04-01		Applicant
WO9953899	1998-04-01		Applicant
WO98/20861	1998-05-01		Applicant
WO98/21203	1998-05-01		Applicant
WO98/30341	1998-07-01		Applicant
WO9830341	1998-07-01		Applicant
WO98/43673	1998-10-01		Applicant
WO98/55148	1998-12-01		Applicant
WO9902135	1999-01-01		Applicant
WO99/03449	1999-01-01		Applicant
WO9907347	1999-02-01		Applicant
WO9908658	1999-02-01		Applicant
WO99/10017	1999-03-01		Applicant
WO9918938	1999-04-01		Applicant
WO99/20261	1999-04-01		Applicant
WO99/20271	1999-04-01		Applicant
WO99/22769(A1)	1999-05-01		Applicant
WO99/24020	1999-05-01		Applicant
WO9938495	1999-08-01		Applicant
WO99/43343	1999-09-01		Applicant
WO9320709	1999-10-01		Applicant
WO99/49835	1999-10-01		Applicant
WO99/49895	1999-10-01		Applicant
WO99/51089	1999-10-01		Applicant
WO9953899	1999-10-01		Applicant
WO9955313	1999-11-01		Applicant
WO99/55704	1999-11-01		Applicant
WO99/56761	1999-11-01		Applicant
WO1370	2000-01-01		Applicant
WO10538	2000-03-01		Applicant
WO18374	2000-04-01		Applicant
WO28974	2000-05-01		Applicant
WO/45794	2000-08-01		Applicant
WO126633	2000-10-01		Applicant
WO74655	2000-12-01		Applicant
WO103677	2001-01-01		Applicant
WO1/32150	2001-05-01		Applicant
WO1/32152	2001-05-01		Applicant
WO2/43694	2002-06-01		Applicant

Non-Patent Literature (34)

Alginates for Pharmaceutical Applications, http://www.isp-pharma.com/library/algnpharm/algnpham., Oct. 20, 2000.Examiner
Ritschel, “Die Tablette”,Der Pharmazeutische Betrieb, 1996, no month provided 7:41-48, 366-371.Applicant
Rothe & Groppenbacher, “Filmdragierung auf waBriger Basis”, Die Pharmazeutische Industrie,1972, no month provided 34:892-894, p. 3-8.Applicant
Rothe & Groppenbacher, “Filmdragierung nach dem Tauchrohr-Verfahren”, Die Pharmazeutische Industrie, 1973, no month privided 35:723-729, p. 3-12.Applicant
Chemical Abstracts, vol. 100, No. 23, Jun. 4, 1984 abstract 100: 190544j.Applicant
Chemical Abstracts, vol. 101, No. 11, Sep. 10, 1984 abstract 101: 89243f.Applicant
Chemical Abstracts. vol. 101, No. 17, Oct. 22, 1984 abstract 101: 150241x.Applicant
Rowe, “Some Fundamental Properties Of Polymeric Materials And Their Application In Film Coating Formulations” Int. J. Pharm. Tech & Prod, Mfr., (3) 1982.Applicant
Rowe & Forse, “The Effect Of Polymer Molecular Weight On The Incidence Of Cracking And Solitting On Film Coated Tablets”, Communications, J. Pharm. Pharmacol, 1980, 32:583.Applicant
Possible translation of JP 51-123815 Oct. 1976.Applicant
Possible translation of JP 49-133515 Dec. 1974.Applicant
Okhamafe A. et al, J. Pharm. Pharmacol. 37. 449-454, 1985 no month provided “Stress Crack Resistance . . . Tablet Film Coating Systems”.Applicant
Okhamafe A. et al, J. Pharm. Pharmacol. 41: 1-6, 1989 no date provided “Thermal Characterization . . . Film Coating Formulation”.Applicant
File History re Opposition Proceedings re EP-0551700 no month provived no date provided.Applicant
Tranlation of WO 99/07347 no date provided.Applicant
International Search Report and Written Opinion for PCT/US00/29848 no date provided.Applicant
Fenerna, “Food Chemistry,” 3rd Edition, pp 221-214 no date provided.Applicant
Leon Lachman, Herbert Lieberman & Joseph Kanig, The Theory and Practice of Industrial Pharmacy, 3rd ed. (Philadelphia, PA.: Lea & Febiger, 1986), no month provided pp76-77,321,327-328.Applicant
Kirk-Othmer Encyclopedia of Chemical Technology; vol. 4, pp. 653-661., John Wiley & Sons, Inc. (1964) (no month provided).Applicant
PCT/US00/21397 Search Report dated Nov. 20, 2000.Applicant
Colliopoulos, J.A., et al., “Rheological properties of microcrystaline cellulose (MCC) carrageenan aqueous film coating,” Annual Meeting, Nov. 14-18, 1999, AAPS Abstract No. 3480, 1 page.Applicant
Dell, S.M., et al., “Evaluation of mechanical properties of free films of aqueous coating systems,” Annual Meeting, Nov. 14-18, 1999, AAPS Abstract No. 2906, 1 page.Applicant
Dell, S.M. et al., “Evaluation of Microcrystalline cellulous (MCC): carrageenan mixture as a film former in conventional aqueous film coating,” Annual Meeting, Nov. 14-18, 1999, AAPS Abstract No. 2925, 1 page.Applicant
Lee, J.T., “Evaluation of the functional stability of microcrystalline cellulose (MCC): carrageenan conventional aqueous film coating,” Annual Meeting, Nov. 14-18, 1999, AAPS Abstract No. 3459, 1 page.Applicant
Karen L. Moore, “Physicochemical Properties of Opadry, Coateric and Surelease,” Chapter 7 of Aqueous Polymeric Coatings for Pharmaceutical Dosage Forms, pp. 303-315 (Marcef Dekker, Inc). no date provided.Applicant
“A clear advance in convential coatings,” Introducing Lustre Clear™ Microcrystalline Cellulose/Carrageenan-Based Coating System brochure, FMC BioPolymer, (1999), 17 pages.Applicant
Supplementary European Search Report for Application No. EP 00 90 7193.Applicant
The Use of Carrageenan in Mixture with Microcrystalline Cellulose and its Functionality for Making Tablets., Katharine M. Picker, European Journal of Pharmaceutics and Biopharmaceutics.,48(1), pp. 27-36 (1999).Applicant
PCT/US01/44378 Search Report dated Apr. 9, 2002.Applicant
PCT/US02/13668 Search Report dated Aug. 18, 2002.Applicant
Alginates for Pharmaceutical Applications, http://www.isp-pharma.com/library/algnpharm/algnpharm., Oct. 20, 2000, see entire document.Applicant
PCT/US00/03130 Search Report dated May 25, 2000 and Written Opinion dated Feb. 16, 2001.Applicant
PCT/US00/32150 Search Report dated Nov. 20, 2000 and Written Opinion dated Jul. 25, 2001.Applicant
PCT/US00/29849 Search Report dated Jan. 25, 2001.Applicant